JP2014521642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521642A5 JP2014521642A5 JP2014522853A JP2014522853A JP2014521642A5 JP 2014521642 A5 JP2014521642 A5 JP 2014521642A5 JP 2014522853 A JP2014522853 A JP 2014522853A JP 2014522853 A JP2014522853 A JP 2014522853A JP 2014521642 A5 JP2014521642 A5 JP 2014521642A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazolidin
- ylidene
- pyridin
- amine
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161511372P | 2011-07-25 | 2011-07-25 | |
| US61/511,372 | 2011-07-25 | ||
| PCT/US2012/046161 WO2013015984A1 (en) | 2011-07-25 | 2012-07-11 | N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014521642A JP2014521642A (ja) | 2014-08-28 |
| JP2014521642A5 true JP2014521642A5 (enExample) | 2016-08-25 |
| JP6052685B2 JP6052685B2 (ja) | 2016-12-27 |
Family
ID=46551906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522853A Expired - Fee Related JP6052685B2 (ja) | 2011-07-25 | 2012-07-11 | α２アドレナリン受容体の調節因子としてのＮ−（イミダゾリジン−２−イリデン）−ヘテロシクロペンタ［ｂ］ピリジン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8513419B2 (enExample) |
| EP (1) | EP2736906B1 (enExample) |
| JP (1) | JP6052685B2 (enExample) |
| KR (1) | KR20140082643A (enExample) |
| CN (1) | CN103781785A (enExample) |
| AU (1) | AU2012287338A1 (enExample) |
| BR (1) | BR112014001951A2 (enExample) |
| CA (1) | CA2843245A1 (enExample) |
| IL (1) | IL230653A (enExample) |
| MX (1) | MX336578B (enExample) |
| RU (1) | RU2014106367A (enExample) |
| WO (1) | WO2013015984A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2843611B2 (ja) | 1989-09-14 | 1999-01-06 | 中外製薬株式会社 | 水酸基ラジカル消去剤 |
| AU2016276316B2 (en) | 2015-06-09 | 2020-01-23 | Abbvie Inc. | Nuclear receptor modulators |
| WO2016198908A1 (en) | 2015-06-09 | 2016-12-15 | Abbvie Inc. | Ror nuclear receptor modulators |
| KR200490025Y1 (ko) | 2018-05-11 | 2019-09-11 | 고양시농업기술센터 | 포트의 보관이 가능한 화분기구 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
| AU704972B2 (en) | 1994-08-04 | 1999-05-13 | H. Lundbeck A/S | Novel benzimidazole derivatives |
| US5677321A (en) * | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
| JP2001506601A (ja) * | 1996-11-25 | 2001-05-22 | ザ プロクター アンド ギャンブル カンパニー | α―２アドレナリン受容体作動薬として有用な２―イミダゾリニルアミノベンゾオキサゾール化合物 |
| WO1998023612A1 (en) * | 1996-11-25 | 1998-06-04 | The Procter & Gamble Company | 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists |
| US5866579A (en) | 1997-04-11 | 1999-02-02 | Synaptic Pharmaceutical Corporation | Imidazole and imidazoline derivatives and uses thereof |
| EP2486009B1 (en) * | 2009-10-06 | 2019-08-21 | Allergan, Inc. | 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
-
2012
- 2012-07-11 CN CN201280043028.2A patent/CN103781785A/zh active Pending
- 2012-07-11 WO PCT/US2012/046161 patent/WO2013015984A1/en not_active Ceased
- 2012-07-11 EP EP12738322.2A patent/EP2736906B1/en not_active Not-in-force
- 2012-07-11 CA CA2843245A patent/CA2843245A1/en not_active Abandoned
- 2012-07-11 RU RU2014106367/04A patent/RU2014106367A/ru not_active Application Discontinuation
- 2012-07-11 AU AU2012287338A patent/AU2012287338A1/en not_active Abandoned
- 2012-07-11 MX MX2014001060A patent/MX336578B/es unknown
- 2012-07-11 JP JP2014522853A patent/JP6052685B2/ja not_active Expired - Fee Related
- 2012-07-11 US US13/546,211 patent/US8513419B2/en active Active
- 2012-07-11 BR BR112014001951A patent/BR112014001951A2/pt not_active IP Right Cessation
- 2012-07-11 KR KR1020147004721A patent/KR20140082643A/ko not_active Withdrawn
-
2013
- 2013-07-18 US US13/945,825 patent/US8741921B2/en active Active
-
2014
- 2014-01-26 IL IL230653A patent/IL230653A/en active IP Right Grant
- 2014-04-21 US US14/257,517 patent/US9034896B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017219063B2 (en) | Urea derivatives and uses thereof | |
| US10927079B2 (en) | Intermediate compound of novel tetrahydronaphthyl urea derivative | |
| JP2014521642A5 (enExample) | ||
| RU2012134639A (ru) | Фармацевтический препарат для предупреждения и лечения нарушений, сопровождающихся глазным ангиогенезом и/или повышенной проницаемостью сосудов глаза | |
| RU2016121150A (ru) | Терапевтическое средство против заболеваний, связанных с гибелью клеток эндотелия роговицы, обусловленной состоянием эндоплазматического ретикулума | |
| JP6738512B2 (ja) | 眼血管形成（ｏｃｕｌａｒ ｎｅｏｖａｓｃｕｌａｎ）を治療するのに有用な化合物 | |
| JP2013540749A5 (enExample) | ||
| MY176525A (en) | Therapeutic agent for ocular disease or prophylactic agent for ocular disease | |
| CN106604730B (zh) | 角膜厚度调节剂 | |
| US20130303539A1 (en) | Compounds with trpv4 activity, compositions and associated methods thereof | |
| RU2014106367A (ru) | N-(ИМИДАЗОЛИДИН-2-ИЛИДЕН)-ГЕТЕРОЦИКЛОПЕНТА[b]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ АЛЬФА 2 АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ | |
| JP2020513017A (ja) | 眼疾患の予防方法又は処置方法 | |
| JP6849668B2 (ja) | ピリジン又はピリミジン誘導体 | |
| AU2012237066B2 (en) | Pharmaceutical composition for preventing or treating macular degeneration | |
| AU2014275198B2 (en) | Novel compounds and uses thereof | |
| JP2014521647A5 (enExample) | ||
| JP2002104968A (ja) | 毛様体筋の緊張緩和剤 | |
| RU2014106364A (ru) | Производные n-(имидазолидин-2-илидин)хинолина как модуляторы адренергических рецепторов альфа-2 | |
| WO2015187850A2 (en) | Compounds and methods for treatment of ocular disorders | |
| Shahsuvaryan | Diabetic Retinopathy: The Promise of New Druggable Target | |
| Merkoudis et al. | Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye-a case report. | |
| AU2015360438B2 (en) | 1 -amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof | |
| HK40051528A (en) | Integrin antagonists |